XML 32 R21.htm IDEA: XBRL DOCUMENT
v3.8.0.1

Summary of Significant Accounting Policies (Tables) | 3 Months Ended
--- | ---
Mar. 31, 2018
Accounting Policies [Abstract] |
Schedule of Changes in Contract Assets and Liabilities | The following table present changes in our contract assets and liabilities during the three months ended March 31, 2018 and 2017:
|  | Balance at Beginning of Period |  |  | Revenue Recognized in Advance of Billings |  |  | Billings |  |  | Balance at End of Period |
Three months ended March 31, 2018 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Contract assets: Unbilled receivables |  | $ | 57,169 |  |  | $ | 21,420 |  |  | $ | - |  |  | $ | 78,589 |
Three months ended March 31, 2017 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Contract assets: Unbilled receivables |  | $ | - |  |  | $ | 100,937 |  |  | $ | - |  |  | $ | 100,937 |
|  | Balance at Beginning of Period |  |  | Billings |  |  | Recognized Revenue |  |  | Balance at End of Period |
Three months ended March 31, 2018 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Contract liabilities: Deferred revenue |  | $ | 703,981 |  |  | $ | 697,282 |  |  | $ | (796,510 | ) |  | $ | 604,753 |
Three months ended March 31, 2017 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Contract liabilities: Deferred revenue |  | $ | 665,460 |  |  | $ | 908,668 |  |  | $ | (1,031,539 | ) |  | $ | 542,589 |
Schedule of Adoption of New Revenue | Adoption of the new revenue standard impacted our reported results as follows:
|  | For the Three Months Ended March 31, 2017 |
|  | As Reported |  |  | New Revenue Standard Adjustment |  |  | As Adjusted |
Condensed Consolidated Statements of Operations: |  |  |  |  |  |  |  |  |  |  |  |
Revenues |  | $ | 710,394 |  |  | $ | (2,777 | ) |  | $ | 707,617 |
Operating expenses |  |  | 820,128 |  |  |  | (1,292 | ) |  |  | 818,836 |
Net loss |  |  | (448,709 | ) |  |  | (1,485 | ) |  |  | (450,194 | )
Basic and diluted net loss per share |  |  | (0.03 | ) |  |  | - |  |  |  | (0.03 | )
|  | For the Twelve Months Ended December 31, 2017 |
|  |  | As Reported |  |  | New Revenue Standard Adjustment |  |  | As Adjusted |
Condensed Consolidated Statements of Operations: |  |  |  |  |  |  |  |  |  |  |  |
Revenues |  | $ | 2,623,441 |  |  | $ | (3,334 | ) |  | $ | 2,620,107 |
Operating expenses |  |  | 3,031,555 |  |  |  | 2,694 |  |  |  | 3,034,249 |
Net loss |  |  | (1,359,337 | ) |  |  | (6,028 | ) |  |  | (1,365,365 | )
Basic and diluted net loss per share |  |  | (0.08 | ) |  |  | - |  |  |  | (0.08 | )
|  | For the Twelve Months Ended December 31, 2016 |
|  | As Reported |  |  | New Revenue Standard Adjustment |  |  | As Adjusted |
Condensed Consolidated Statements of Operations: |  |  |  |  |  |  |  |  |  |  |  |
Revenues |  | $ | 2,601,733 |  |  | $ | (828 | ) |  | $ | 2,600,905 |
Operating expenses |  |  | 3,261,903 |  |  |  | 1,565 |  |  |  | 3,263,468 |
Net loss |  |  | (1,576,311 | ) |  |  | (2,393 | ) |  |  | (1,578,704 | )
Basic and diluted net loss per share |  |  | (0.09 | ) |  |  | - |  |  |  | (0.09 | )
|  | March 31, 2017 |
|  | As Reported |  |  | New Revenue Standard Adjustment |  |  | As Adjusted |
Condensed Consolidated Balance Sheets: |  |  |  |  |  |  |  |  |  |  |  |
Accounts payable and accrued expenses |  | $ | 736,415 |  |  | $ | 273 |  |  | $ | 736,688 |
Deferred revenue |  |  | 538,985 |  |  |  | 3,605 |  |  |  | 542,590 |
Accumulated deficit |  |  | (15,403,459 | ) |  |  | (3,878 | ) |  |  | (15,407,337 | )
|  | December 31, 2017 |
|  | As Reported |  |  | New Revenue Standard Adjustment |  |  | As Adjusted |
Condensed Consolidated Balance Sheets: |  |  |  |  |  |  |  |  |  |  |  |
Accounts payable and accrued expenses |  | $ | 471,200 |  |  | $ | 4,259 |  |  | $ | 475,459 |
Deferred revenue |  |  | 703,971 |  |  |  | 4,162 |  |  |  | 708,133 |
Accumulated deficit |  |  | (16,314,087 | ) |  |  | (8,421 | ) |  |  | (16,322,508 | )
|  | December 31, 2016 |
|  | As Reported |  |  | New Revenue Standard Adjustment |  |  | As Adjusted |
Condensed Consolidated Balance Sheets: |  |  |  |  |  |  |  |  |  |  |  |
Accounts payable and accrued expenses |  | $ | 767,197 |  |  | $ | 1,565 |  |  | $ | 768,762 |
Deferred revenue |  |  | 665,460 |  |  |  | 828 |  |  |  | 666,288 |
Accumulated deficit |  |  | (14,954,750 | ) |  |  | (2,393 | ) |  |  | (14,957,143 | )

X
- Definition Schedule of Changes in Contract Assets and Liabilities [Table Text Block] + References No definition available. + Details
Name: | INLX_ScheduleOfChangesInContractAssetsAndLiabilitiesTableTextBlock
Namespace Prefix: | INLX_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of condensed financial statements, including, but not limited to, the balance sheet, income statement, and statement of cash flows. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 3 -Paragraph i -Subsection 10 + Details
Name: | srt_ScheduleOfCondensedFinancialStatementsTableTextBlock
Namespace Prefix: | srt_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_AccountingPoliciesAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration